Subscribe to Newsletter

September 2016 Issue of The Pathologist

“Welcome to our September issue. This month, our Upfront articles tackle testing for Lynch syndrome and lipid disorders and look at a new technique for rapidly identifying pathogens. In My View contains pathology residents’ recommendations for improving medical school curricula before it’s too late. Our Feature is a gallery showcasing images from all fields of laboratory medicine, created and submitted by the experts – you. In Practice discusses the Blueprint Project aiming to compare and characterize PD-L1 assays and the practical implementation of long-distance diagnostics. NextGen includes blood biomarkers for asthma and software to diagnose infectious diseases, whereas Profession calls for better regulation of diagnostic tests. We Sit Down With Ivan Damjanov, pathologist and expert educator at the University of Kansas School of Medicine.”

Register to download
Register here to download any issue of The Pathologist for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Inside the Lab Profession

Humble Versus Harmful

| Fedra Pavlou

Lab medicine saves lives every day in humanitarian crises – why does nobody talk about it?
Outside the Lab Oncology

Reflex Recommendations

| Michael Schubert

RCPath and Bowel Cancer UK call for improved Lynch syndrome testing in young patients
Inside the Lab Biochemistry and molecular biology

A New Angle on CKD

| Michael Schubert

D-amino acid levels may reveal which CKD patients are at greatest risk of progression
Outside the Lab Screening and monitoring

To Screen or Not to Screen?

| Michael Schubert

Are the benefits of childhood lipid disorder screening worth the costs and risks?
Diagnostics Oncology

How the Bullet Lost its Magic

| Michael Schubert

Changes in P-glycoprotein expression could explain leukemia patients' treatment resistance
Outside the Lab Microscopy and imaging

Waging War on Resistance

| Michael Schubert

Automated digital microscopy reduces time to diagnose multidrug-resistant infections
Inside the Lab Profession

The Pathologist’s 2016 Power List

The Pathologist’s 2016 “Rising Stars” Power List nominations are now open!
Inside the Lab Training and education

Undermined and Undervalued

| H. Cliff Sullivan

Practical ideas for changing medical school curricula before it’s too late for pathology.
Inside the Lab Microscopy and imaging

Through the Looking Glass

| Michael Schubert

The beautiful world of pathology seen through a gallery of laboratory medicine images.
Inside the Lab Digital and computational pathology

Through the Looking Glass Continued

| Michael Schubert

The beautiful world of pathology seen through a gallery of laboratory medicine images.
Outside the Lab Quality assurance and quality control

A Blueprint for the Future

| Henrik Winther and Hans Christian Pedersen

Industry and regulators collaborate to harmonize or consolidate PD-1/PDL-1 assays
Outside the Lab Profession

Diagnostics at a Distance

| Sebastian Brandner

How one neuropathology institute provides full diagnostic services to a remote hospital
Diagnostics Genetics and epigenetics

From Blood to Breath

| Faoud Ishmael

Circulating miRNAs may serve as noninvasive biomarkers for respiratory disorders
Diagnostics Technology and innovation

Diagnosis Ex Machina

| Robert Schlaberg

A new software tool may return faster, more accurate infectious disease diagnoses
Outside the Lab Profession

Quis Custodiet?

| Patrick Bossuyt

Diagnostic tests are not evaluated as rigorously as pharmaceuticals, but this must change
Outside the Lab Training and education

The Changing Man

| Fedra Pavlou

Ivan Damjanov, Professor of Pathology, University of Kansas School of Medicine, Kansas City, USA
Outside the Lab Screening and monitoring

Micro Sample, Maximum Outcome

Next-generation microsampling overcomes limitations of traditional DBS and wet sampling.

Other issues of 2016